glp-1 for long covid Researchers are launching a new study to investigate whether drugs, already approved type 2 diabetes and obesity, could help treat symptoms. The medications are currently being studied for Scripps Research has launched a

The relationship between GLP-1 receptor agonists and inner-ear or neurological symptoms remains an area of ongoing clinical observation, and individual responses vary widely based on genetics, starting dose, and overall health status

The Next GLP-1 Wave: How Oral Launches Could Accelerate Utilization and Risk GLP-1 agents have reshaped the management of obesity, and the market continues to accelerate as new agents and indications emerge

Fiber (particularly soluble fiber like psyllium) has its own evidence base for constipation management and is often used alongside probiotics

The prevalence among the general population is 1.17/1,000, with an incidence of 25/100,000 (2,3)